Clinical Trial Update: Clinical Trial Assessing 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Anterior Resection Syndrome [EARLY_Phase 1]

View source ↗

Summary

A clinical trial update from Seoul National University Hospital evaluating Ramosetron, a 5-HT3 receptor antagonist, for the treatment of anterior resection synd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Resection Syndrome

Drugs mentioned

• Ramosetron (ramosetron)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Anterior Resection Syndrome | EARLY_Phase 1 | Status: UNKNOWN